Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Matthew E. Sherman, Colton J. Sheehan, Igor E. Brodsky, Sunny Shin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1038/nrmicro1068
10.1038/nrmicro1068
Bacterial lipids: powerful modifiers of the innate immune response
10.12688/f1000research.11388.1 · 2017
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inffammatory Pathways
10.3389/fimmu.2020.585146 · 2020
10.1146/annurev.biochem.76.010307.145803
10.1146/annurev.biochem.76.010307.145803
10.1038/nrmicro3047
10.1038/nrmicro3047
10.1038/s41579-019-0201-x
10.1038/s41579-019-0201-x
10.1146/annurev-biochem-060713-035600
10.1146/annurev-biochem-060713-035600
Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae
2005
The Glycosyltransferases of LPS Core: A Review of Four Heptosyltransferase Enzymes in Context
10.3390/ijms18112256 · 2017
10.1021/bi061767s
10.1021/bi061767s
10.1074/jbc.m110.166314
10.1074/jbc.m110.166314
10.1111/j.1365-2958.2010.07305.x
10.1111/j.1365-2958.2010.07305.x
Francisella FlmX broadly affects lipopolysaccharide modification and virulence
10.1016/j.celrep.2021.109247 · 2021
10.1038/nature07830
10.1038/nature07830
Lipid A Variants Activate Human TLR4 and the Noncanonical Inffammasome Differently and Require the Core Oligosaccharide for Inffammasome Activation
10.1128/iai.00208-22 · 2022
10.1128/iai.00201-22
10.1128/iai.00201-22
10.1177/1753425917695446
10.1177/1753425917695446
10.1038/s41598-018-36811-4
10.1038/s41598-018-36811-4
10.1016/j.immuni.2025.12.017
10.1016/j.immuni.2025.12.017
10.1038/s41590-019-0368-3
10.1038/s41590-019-0368-3
10.1038/nature13820
10.1038/nature13820
10.1126/science.1230751
10.1126/science.1230751
10.1126/science.1240988
10.1126/science.1240988
10.1126/science.1240248
10.1126/science.1240248
10.1084/jem.20180589
10.1084/jem.20180589
10.26508/lsa.201800237
10.26508/lsa.201800237
10.7554/elife.83725
10.7554/elife.83725
10.1126/sciadv.adt9027
10.1126/sciadv.adt9027
The dynamic and heterogeneous structure of the non-canonical inffammasome
10.1073/pnas.2613431123 · 2026
10.1126/sciadv.adz4623
10.1126/sciadv.adz4623
10.1038/cr.2015.139
10.1038/cr.2015.139
10.1038/nature15541
10.1038/nature15541
10.1038/nature15514
10.1038/nature15514
10.1038/nature18629
10.1038/nature18629
10.1038/nature10558
10.1038/nature10558
10.1128/mbio.02975-23
10.1128/mbio.02975-23
10.1038/s41577-025-01142-9
10.1038/s41577-025-01142-9
10.1016/j.immuni.2016.11.007
10.1016/j.immuni.2016.11.007
10.1128/iai.49.1.164-171.1985
10.1128/iai.49.1.164-171.1985
10.1128/iai.63.1.229-237.1995
10.1128/iai.63.1.229-237.1995
10.1016/j.ab.2004.12.001
10.1016/j.ab.2004.12.001 · doi-reference
10.1021/ac60111a017
10.1021/ac60111a017 · doi-reference
10.1007/978-1-0716-1900-1_14
10.1007/978-1-0716-1900-1_14 · doi-reference
10.1007/978-1-4939-6958-6_16
10.1007/978-1-4939-6958-6_16 · doi-reference
10.1194/jlr.d500014-jlr200
10.1194/jlr.d500014-jlr200 · doi-reference
10.1021/acs.analchem.1c05394
10.1021/acs.analchem.1c05394 · doi-reference
10.1038/s41598-020-78401-3
10.1038/s41598-020-78401-3 · doi-reference
10.1016/0008-6215(88)84149-1
10.1016/0008-6215(88)84149-1 · doi-reference
10.1111/j.1432-1033.1969.tb00601.x
10.1111/j.1432-1033.1969.tb00601.x · doi-reference
Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2
10.4049/jimmunol.165.2.618 · doi-reference
10.1007/s10858-011-9570-9
10.1007/s10858-011-9570-9 · doi-reference
10.3791/3916-v
10.3791/3916-v · doi-reference
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
10.1016/j.vaccine.2025.126779 · doi-reference
10.1186/1471-2180-6-39
10.1186/1471-2180-6-39 · doi-reference
10.1128/iai.01242-06
10.1128/iai.01242-06 · doi-reference
10.1111/j.1574-695x.2009.00580.x
10.1111/j.1574-695x.2009.00580.x · doi-reference
Developing live Shigella vaccines using ƛ Red recombineering
10.1111/j.1574-695x.2006.00118.x · doi-reference
Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli
10.1186/1471-2199-4-11 · doi-reference
10.1073/pnas.120163297
10.1073/pnas.120163297 · doi-reference
10.1038/nmeth865
10.1038/nmeth865 · doi-reference
10.1038/s41467-017-02682-y
10.1038/s41467-017-02682-y · doi-reference
Biological Activity of Masked Endotoxin
10.1038/srep44750 · doi-reference
10.1093/oxfordjournals.jbchem.a122276
10.1093/oxfordjournals.jbchem.a122276 · doi-reference
10.1038/s44318-025-00507-z
10.1038/s44318-025-00507-z · doi-reference
Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation
10.1097/shk.0000000000001012 · doi-reference
10.1126/science.aaf3036
10.1126/science.aaf3036 · doi-reference
10.3390/ijms23031204
10.3390/ijms23031204 · doi-reference
10.1074/jbc.m401879200
10.1074/jbc.m401879200 · doi-reference
10.1021/bi00201a002
10.1021/bi00201a002 · doi-reference
10.3390/separations11010034
10.3390/separations11010034 · doi-reference
10.1016/0076-6879(95)50100-2
10.1016/0076-6879(95)50100-2 · doi-reference
A next-generation GMMA-based vaccine candidate to fight shigellosis
10.1038/s41541-023-00725-8 · doi-reference
10.1016/j.celrep.2023.112726
10.1016/j.celrep.2023.112726 · doi-reference
Protocol for reconstitution of oligomeric assembly of NAIP5-NLRC4 inffammasome in vitro
10.1016/j.xpro.2023.102581 · doi-reference
10.21769/bioprotoc.2292
10.21769/bioprotoc.2292 · doi-reference
10.1038/cdd.2014.76
10.1038/cdd.2014.76 · doi-reference
10.1093/glycob/cwm140
10.1093/glycob/cwm140 · doi-reference
10.1128/iai.70.3.1150-1158.2002
10.1128/iai.70.3.1150-1158.2002 · doi-reference